The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
-
-
Trubion Pharmaceutical completed its IPO
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
-
The Biomarkers Consortium was founded
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
-
BD acquired TriPath Imaging for $350 million
On Sept. 8, 2006, BD (Becton, Dickinson) announced an agreement to acquire the 93.5% of the outstanding shares…
-
The National Cancer Institute Annual Report to the Nation found cancer death rates continue to drop
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
-
National Cancer Institute researchers discovered unique pattern of gene activity that predict liver cancer spread
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
-
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
-
Siteman Cancer Center was selected to be part of the National Comprehensive Cancer Network
On Mar. 22, 2006, the Siteman Cancer Center at Barnes-Jewish Hospital and Washington School of Medicine in St….
-
Biotechnology | Diagnostics | Medical Device | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
Dan L. Duncan contributed $100 million to the Baylor Cancer Center
On Jan. 31, 2006, Dan Duncan, founder of Enterprise Partners, an energy company in Houston, announced a donation…
-
NCI launched TAILORx trial to determine whether gene expression patterns in early-stage breast cancer can distinguish women at high risk of recurrence
In 2006, the National Cancer Institute (NCI) launched the TAILORx trial to determine whether gene expression patterns in…
-
The prevalence of U.S. adult smoking declined to 20.8 percent in 2006
In 2006, an estimated 20.8% (45.3 million) of U.S. adults were current cigarette smokers; of these, 80.1% (36.3…
-
The Indiana University Cancer Center renamed Indiana University Melvin and Bren Simon Cancer Center
In 2006, The Indiana University Cancer Center was renamed the Indiana University Melvin and Bren Simon Cancer Center….
-
Calistoga Pharmaceuticals was founded
In 2006, Calistoga Pharmaceuticals was founded as a Seattle-based spin-off from ICOS Corp. that was dedicated to developing…
-
Diagnostics | Disease | Genomics | Oncology | Therapeutics
NCI and NHGRI launched effort to accelerate understanding molecular basis of cancer with genome analysis
On Dec. 13, 2005, the National Cancer Institute (NCI) and the National Human Genome Research Institute launched a…
-
Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively for cancer patients
On Dec. 1, 2005, the Barbara Ann Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively…
-
National Cancer Institute launched a cancer biorepository pilot project to standardize biospecimen collection
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
-
The National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer initiative
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
-
Annual Report to the Nation on the Status of Cancer showed cancer death rates dropped from 1993-2002
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
-
Siteman Cancer Center opened a new center at Barnes-Jewish St Peters Hospital
On Sept. 22, 2005, the Siteman Cancer Center opened a new center at Barnes-Jewish St. Peters Hospital. The…
-
The National Cancer Institute approved a $10 million award for OHSU Cancer Institute
On Jul. 18, 2005, Oregon Health & Science University (OHSU) announced receipt of a five-year, $10 million award…
-
Biotechnology | Disease | NIH | Oncology | Therapeutics
The Patient Navigator Outreach and Chronic Disease Prevention Act amended the Public Health Service Act
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
-
Biotechnology | Genomics | NIH | Oncology | Therapeutics
The National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid
On Apr. 12, 2005, the National Cancer Institute (NCI) announced the creation of the cancer Biomedical Informatics Grid…
-
World Cancer Day was established by The World Health Organization
On Feb. 4, 2005, World Cancer Day was established by The World Health Organization. Cancer is a leading…
-
The Georgia Legislature passed the Smoke Free Air Act
In 2005, the Georgia Legislature passed the Smoke Free Air Act, banning indoor smoking in publicly accessible buildings,…
-
Diagnostics | Disease | NIH | Oncology
The Patient Navigator Research Program assessed impact of patient navigators
In 2005, The Patient Navigator Research Program (PNRP), a National Cancer Institute initiative, was underway to assess the…
-
UW Doctor performed SCCA’s first video-assisted thoracic surgery
In 2005, Dr. Michael Mulligan from the University of Washington performed Seattle Cancer Care Alliance’s (SCCA) first video-assisted…
-
FDA approved Kepivance for severe oral mucositis in cancer patients undergoing bone marrow transplant
On Dec. 15, 2004, Amgen announced that following priority review, the FDA has approved Kepivance(TM) (palifermin), the first…
-
UI Microbiology Professor Mark Stinski made the discoveries of CMV promoter and was named Iowa Inventor of the Year
On Sept. 30, 2003, University of Iowa (UI) Microbiology Professor Mark Stinski made the discoveries of CMV promoter…
-
The National Cancer Institute announced the Alliance for Nanotechnology in Cancer
On Sept. 13, 2004, the National Cancer Institute announced the Alliance for Nanotechnology in Cancer, a 5-year initiative…
-
Biotechnology | FDA | Medicine | Oncology | Therapeutics
FDA approved the first antiangiogenic drug for cancer, Avastin
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
